Company Filing History:
Years Active: 2010
Title: Birendra Kumar Bhattacharya: Innovator in Pharmaceutical Compounds
Introduction
Birendra Kumar Bhattacharya is a notable inventor based in Union City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have the potential to treat various health conditions.
Latest Patents
Birendra Kumar Bhattacharya holds a patent for "Heterocyclic diphenyl ethers." This invention relates to novel heterocyclic diphenyl ether and diphenyl amine compounds, including their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, and compositions. The compounds are effective in lowering blood glucose, serum insulin, free fatty acids, cholesterol, and triglyceride levels. They are useful in the treatment and/or prophylaxis of diabetes, obesity, inflammation, autoimmune diseases such as multiple sclerosis and rheumatoid arthritis, and immunological diseases, including cancer. Furthermore, these compounds are beneficial for treating disorders associated with insulin resistance. He has 1 patent to his name.
Career Highlights
Birendra Kumar Bhattacharya is associated with Bexel Pharmaceuticals, Inc., where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing effective treatments for various medical conditions, showcasing his commitment to improving health outcomes.
Collaborations
He has collaborated with notable coworkers, including Partha Neogi and Bishwajit Nag, to advance research and development in his field.
Conclusion
Birendra Kumar Bhattacharya's innovative work in pharmaceutical compounds highlights his dedication to addressing critical health issues. His contributions have the potential to make a significant impact on the treatment of various diseases.